In a chemotherapy patient with an absolute neutrophil count of 1.4 ×10⁹/L, no fever, but presenting with dysphagia, sore throat, and dyspnea, should I initiate empiric broad‑spectrum antibiotics?

Yes, initiate empiric broad-spectrum intravenous antibiotics immediately and admit this patient to the hospital.

Despite the absence of fever, your patient meets high-risk criteria for neutropenic sepsis due to the combination of significant symptoms (dysphagia, sore throat, dyspnea) suggesting pneumonia or severe pharyngeal infection in the setting of chemotherapy-induced neutropenia. This clinical presentation warrants the same aggressive management as febrile neutropenia.

Risk Stratification

Your patient is high-risk based on IDSA criteria 1:

• Significant medical comorbidities present: Pneumonia (suggested by dyspnea) and severe pharyngeal infection (dysphagia, sore throat) are explicitly listed as high-risk features requiring hospitalization
• Afebrile neutropenic patients with new signs or symptoms suggestive of infection should be evaluated and treated as high-risk patients 1
• The white count of 1.4 × 10⁹/L indicates neutropenia, though you need the absolute neutrophil count (ANC) for precise risk assessment

Immediate Management Algorithm

1. Obtain Cultures Before Antibiotics 1

• At least 2 sets of blood cultures (from central line lumens if present, plus peripheral)
• Throat culture/swab
• Chest radiograph is mandatory given dyspnea 1

2. Initiate IV Empiric Antibiotics Within 1 Hour 2

First-line monotherapy options 1:

• Cefepime
• Meropenem or imipenem-cilastatin
• Piperacillin-tazobactam

3. Consider Adding Vancomycin 1

You should add vancomycin (or another gram-positive agent) to your initial regimen because your patient has:

• Pneumonia documented by symptoms (dyspnea) - this is a specific indication for vancomycin 1
• Severe pharyngeal involvement (dysphagia, sore throat) suggesting possible soft-tissue infection

The standard recommendation is that vancomycin is NOT routine for neutropenic fever 1, but pneumonia is explicitly listed as an indication for adding gram-positive coverage 1.

4. Hospital Admission Required 1

• High-risk patients require hospitalization for IV empirical therapy
• Daily monitoring with physical examination and imaging as needed

Critical Clinical Reasoning

Why Treat Without Fever?

The guideline explicitly states: "Afebrile neutropenic patients who have new signs or symptoms suggestive of infection should be evaluated and treated as high-risk patients" 1. Your patient has three concerning symptoms:

1. Dyspnea = possible pneumonia (high-risk feature)
2. Dysphagia + sore throat = severe pharyngeal infection/mucositis with potential airway compromise
3. Neutropenia = impaired immune response may prevent typical fever response

Antibiotic Selection Nuances

• Monotherapy with anti-pseudomonal β-lactam is standard 1
• Add vancomycin for pneumonia - this is evidence-based, not just "consideration" 1
• If patient has received fluoroquinolone prophylaxis, avoid fluoroquinolone-based regimens 1
• Gram-negative organisms predominate (73.7%) but with high resistance rates (23.5-55.6% to common antibiotics) 3

Common Pitfalls to Avoid

1. Don't wait for fever to develop - neutropenic patients may not mount fever response, and delay increases mortality
2. Don't use oral antibiotics - respiratory symptoms and dysphagia make this patient unsuitable for outpatient oral therapy
3. Don't omit chest imaging - dyspnea mandates chest radiograph 1
4. Don't forget to discontinue vancomycin after 2-3 days if no gram-positive organism is identified 1

Reassessment at 2-4 Days 1

• If cultures negative and patient stable/afebrile: continue initial regimen
• If persistent instability: broaden coverage for resistant organisms, anaerobes, and fungi 1
• Median time to defervescence is 5 days in hematologic malignancies, 2 days in solid tumors 1

The combination of respiratory symptoms and pharyngeal involvement in a neutropenic patient constitutes a medical emergency requiring immediate broad-spectrum IV antibiotics with hospital admission, regardless of temperature.